EPHA4

(redirected from SEK)
Also found in: Financial, Acronyms, Wikipedia.

EPHA4

A gene on chromosome 2q36.1 that encodes a member of the ephrin-A receptor subfamily of receptor tyrosine kinases, which promiscuously bind membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signalling into neighbouring cells. EPHA4 mediates developmental events, especially in the nervous system, controlling different steps of axonal guidance (e.g., establishing corticospinal projections) and possibly also controlling segregation of motor and sensory axons during neuromuscular circuit development. It interacts with CDK5, CDK5R1, CHN1, NGEF and SIPA1L1.
Mentioned in ?
References in periodicals archive ?
Income before taxes was SEK 274m and income after taxes was SEK 197m.
She also expressed happiness at the opening of an SEK branch in Qatar.
The purchase consideration for Distansen totals SEK 570m (USD 61.
In the front line of this "unacceptable behaviour" are the ministries of health and labour, SEK added.
The Group has annual sales of approximately SEK 3 billion and about 2,200 employees in 15 countries.
In addition to the initial purchase price there is a possibility for the shareholders of SkA[yen sign]nska Byggvaror to get an additional payment of SEK 110m, if the EBITDA in 2016 exceeds SEK 67m, with a maximum pay-out at an EBITDA of SEK 79m or above.
SEK recently learned that it lost its fight through what s called the bid protest process.
21 May 2013 -- Stockholm-based loan and capital arranger TrustBuddy International AB (OMX: TBDY) said it will be issuing Q1 '13 numbers on 30 May 2013 issued analyst guidance ahead of the report in which the firm aims to reach a lending turnover of SEK 650m in 2013.
All SEK offices will be closed today as the funeral will take place at the Strovolos Cemetery at 11am.
The program will generate annual earnings improvements of SEK 1,300m with full effect from 2015.
M2 EQUITYBITES-November 1, 2016-Medivir to Sell Its BioPhausia Pharmaceutical Unit to Karo Pharma for SEK 908m
Under the deal, Byggmax will acquire all outstanding shares in SkA[yen sign]nska Byggvaror for SEK 74m (USD 8.